Moderna reports positive results in head and neck cancer
PARIS - Moderna shares rose 8 per cent to a three-month high after the company's individualized cancer vaccine developed with ...
PARIS - Moderna shares rose 8 per cent to a three-month high after the company's individualized cancer vaccine developed with ...
WASHINGTON - The US health regulator has approved Japan-based Daiichi Sankyo Co's therapy for newly diagnosed patients with an aggressive ...
Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.
Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.